[HTML] cdc.gov

[HTML][HTML] Early estimates of updated 2023–2024 (monovalent XBB. 1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co …

R Link-Gelles - MMWR. Morbidity and mortality weekly report, 2024 - cdc.gov
Abstract On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023–2024 (updated) COVID-19 vaccination with a monovalent …
被引用次数：49 相关文章

Early Estimates of Updated 2023-2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co …

R Link-Gelles, AA Ciesla, J Mak… - MMWR: Morbidity & …, 2024 - search.ebscohost.com
Abstract On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023-2024 (updated) COVID-19 vaccination with a monovalent …
[PDF] semanticscholar.org

[PDF][PDF] Early Estimates of Updated 2023–2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co …

VEAS SARS-CoV - pdfs.semanticscholar.org
Abstract On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023–2024 (updated) COVID-19 vaccination with a monovalent …
[HTML] cdc.gov

[HTML][HTML] Early Estimates of Updated 2023–2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to …

R Link-Gelles - MMWR. Morbidity and Mortality Weekly Report, 2024 - cdc.gov
Abstract On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023–2024 (updated) COVID-19 vaccination with a monovalent …
[HTML] globaldiasporanews.com

[HTML][HTML] Early Estimates of Updated 2023–2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to …

R Link-Gelles, AA Ciesla, J Mak, JD Miller, BJ Silk… - globaldiasporanews.com
Abstract On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023–2024 (updated) COVID-19 vaccination with a monovalent …
[HTML] nih.gov

[HTML][HTML] Early Estimates of Updated 2023–2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to …

R Link-Gelles, AA Ciesla, J Mak, JD Miller… - … and Mortality Weekly …, 2024 - ncbi.nlm.nih.gov
Abstract On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023–2024 (updated) COVID-19 vaccination with a monovalent …

[引用][C] Early Estimates of Updated 2023–2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co …

R Link-Gelles, AA Ciesla, J Mak, JD Miller… - MMWR. Morbidity and …, 2024 - cir.nii.ac.jp
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness
Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants …

Early Estimates of Updated 2023-2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co …

R Link-Gelles, AA Ciesla, J Mak, JD Miller… - MMWR. Morbidity and …, 2024 - europepmc.org
Abstract On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023–2024 (updated) COVID-19 vaccination with a monovalent …
[PDF] scienceopen.com

[PDF][PDF] Early Estimates of Updated 2023–2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co …

VEAS SARS-CoV - scienceopen.com
Abstract On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023–2024 (updated) COVID-19 vaccination with a monovalent …

Early Estimates of Updated 2023-2024 (Monovalent XBB. 1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co …

R Link-Gelles, AA Ciesla, J Mak… - MMWR. Morbidity …, 2024 - pubmed.ncbi.nlm.nih.gov
On September 12, 2023, CDC's Advisory Committee on Immunization Practices
recommended updated 2023-2024 (updated) COVID-19 vaccination with a monovalent …